Quick takes: RSV vaccine for younger adults, PAHO measles alert, Zimbabwe cholera vaccination
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
Source: umn.edu
Stay updated with breaking news from Mortality Weekly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
No reason other than mild symptoms given for almost half of patients at high risk for progression who were not offered treatment.
SciCheck Digest article debunks claims that COVID-19 vaccination during pregnancy causes autism. A criticized study in rats fails to support these claims.
Fatalities frequently involved Brazilian butt lifts
No reason other than mild symptoms given for almost half of patients at high risk for progression who were not offered treatment.